Overview
This observational study will evaluate the safety and effectiveness of Venetoclax used in routine clinical practice for participants diagnosed with chronic lymphocytic leukemia (CLL).
Eligibility
Inclusion Criteria:
- Participants diagnosed with chronic lymphocytic leukemia who have been prescribed Venetoclax for the first time according to the approved label
- Participants (and/or legal representative) who voluntarily agree to participate in this study and sign informed consent
Exclusion Criteria:
-Participants with contraindications to venetoclax as listed on the approved local label